Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Thyroid function affects skin health, with a complex interaction between the two.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Dermal papilla cells are key for hair growth and could help us understand and treat hair loss.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Cutaneous gene therapy could become a viable treatment for skin and hair disorders with improved vector development and gene expression control.

The document concludes that more research is needed to fully understand the causes of PCOS.

CBD can either reduce inflammation and not affect hair growth at low levels or inhibit hair growth at high levels.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Baicalin may help reduce excessive male hormone levels in PCOS.

Palmitoyl tetrapeptide-20 may help reduce hair greying and increase melanin production.